Nuño P, Hernández A, Mendoza-Figueroa T, Panduro A
Institute of Molecular Biology in Medicine, C.U.C.S. Universidad de Guadalajara, Jalisco, Mexico.
Biochim Biophys Acta. 1997 Feb 18;1344(3):262-9. doi: 10.1016/s0005-2760(96)00150-6.
This study analyzes the relationship of plasmatic colloid osmotic pressure (PCO) and viscosity with the different hyperlipidemic stages observed in rats with acute liver damage induced by carbon tetrachloride (CCl4) and in rats with nephrotic syndrome induced by puromycin amino nucleoside (PAN). In both animal models viscosity increases were associated with the induction of the hyperlipidemic stage characterized by an increase of high density lipoproteins (HDL) and steady-state levels (SSL) of apo A-1 mRNA. In both animal models PCO decreased at early stages of the disease when hyperlipidemia was characterized principally by an increase of total cholesterol and triacylglycerols, but was not associated with the induction of HDL and apo A-1 mRNA. To confirm the in vivo findings, we studied the effect of viscosity on apo A-1 gene expression in an in vitro model using cultured hepatocytes. When medium viscosity was maintained below physiological values, an induction of the SSL of apo A-1 mRNA was observed. By contrast, when medium viscosity was raised to values similar or higher than the physiological range, the SSL of apo A-1 mRNA decreased steadily and after 24 h incubation an almost total inhibition was observed. These results suggest that in both experimental animal models of secondary hyperlipidemia, small viscosity changes below the physiological range, most probably in the interstitial fluid, can induce apo A-1 gene expression at the mRNA level, and that when viscosity reaches physiological values, apo A-1 gene expression is inhibited. Both effects were shown in cultured hepatocytes.
本研究分析了血浆胶体渗透压(PCO)和黏度与四氯化碳(CCl4)诱导的急性肝损伤大鼠及嘌呤霉素氨基核苷(PAN)诱导的肾病综合征大鼠中观察到的不同高脂血症阶段之间的关系。在这两种动物模型中,黏度增加均与以高密度脂蛋白(HDL)增加和载脂蛋白A-1 mRNA稳态水平(SSL)增加为特征的高脂血症阶段的诱导相关。在这两种动物模型中,疾病早期当高脂血症主要以总胆固醇和三酰甘油增加为特征时,PCO降低,但与HDL和载脂蛋白A-1 mRNA的诱导无关。为了证实体内研究结果,我们在体外模型中使用培养的肝细胞研究了黏度对载脂蛋白A-1基因表达的影响。当培养基黏度维持在生理值以下时,观察到载脂蛋白A-1 mRNA的SSL诱导。相比之下,当培养基黏度升高到与生理范围相似或更高的值时,载脂蛋白A-1 mRNA的SSL稳步下降,孵育24小时后观察到几乎完全抑制。这些结果表明,在继发性高脂血症的两种实验动物模型中,生理范围以下的小黏度变化,很可能在组织液中,可在mRNA水平诱导载脂蛋白A-1基因表达,而当黏度达到生理值时,载脂蛋白A-1基因表达受到抑制。这两种效应在培养的肝细胞中均有显示。